Vaccine Competition Is Coming Up And That's A Good Thing

A second major U.S. coronavirus vaccine could possibly be shipped by this weekend.

More Good Vaccine News

There's more good news on the vaccine front. The FDA Finds Moderna Covid-19 Vaccine Highly Effective.

The Food and Drug Administration said Tuesday that the Covid-19 vaccine developed by Moderna Inc. (MRNA)  was “highly effective,” setting the stage for an emergency authorization later this week that would add a second vaccine to the arsenal against the pandemic.

Barring complications, the FDA is aiming to authorize emergency use of the Moderna vaccine Friday, following the same timetable as last week with the first Covid-19 vaccine from Pfizer Inc. (PFE) and BioNTech SE (BNTX).

Moderna’s analysis, posted by the FDA, also included new data suggesting that the first dose of its vaccine can reduce infections that don’t cause symptoms. If this finding holds up in further analysis—including after the second of the two-dose regimen—it could mean that the vaccine not only protects individuals from disease, but also curbs transmission of the virus from person to person.

Moderna has said it expects to have 20 million doses available for the U.S. to ship by the end of 2020, enough to inoculate 10 million people with the two-shot regimen. Moderna, with its own manufacturing plant and working with contract manufacturers, expects to produce between 500 million and 1 billion doses in 2021 for global use.

FDA Analysis

There is no excuse for failure to link to the study, but unfortunately that is typical. 

Here is the FDA Report

Moderna Efficiency

Moderna Efficiency

Moderna Efficiency Final Analysis

Moderna Efficiency Final Analysis

Key Points

  • All 11 cases of severe COVID-19 at least 14 days after second dose as assessed by the  adjudication committee were in the placebo group.
  • Of these 11 participants, 5 had risk factors for severe COVID-19 and 6 did not. 
  • In the primary efficacy analysis, there were an additional 19 cases of severe COVID-19 (one of which resulted in death from COVID-19), for a total of 30 severe COVID-19 cases starting 14 days after dose 2, per adjudication committee assessment. 
  • All 30 cases were in the placebo group. Nine of the total 30 severe COVID-19 cases resulted in hospitalization. 
1 2
View single page >> |

Disclaimer: The content on Mish's Global Economic Trend Analysis site is provided as general information only and should not be taken as investment advice. All site content, including ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Seeking Alpha Reader 4 weeks ago Member's comment

RFK Jr. has represented for 20 +yrs the families of vaccine injured. He's heard all the experts and now is a leading voice for Vaccine Safety, not anti-vaccine. Knows of every instance where the Pharma companies have, been negligent, lied, been criminal, and the likes. Knows every vaccine industry inside and out/ which ones had problems and why they sold to this company or that company, switch names, change adjuvants, move production to another country, and more. Not a pessimistic view of the potential, but a reality which is purposefully hidden. As you probably heard most news you read are owned by a few corporations whose ad revenue comes almost entirely from Pharmaceutical companies. The lobby is the biggest in Washington D.C. Every time a vaccine is added for children and made mandatory it is locked in profits. The opposing voices are silenced. The first goal of global governments proponents is Adult Mandatory vaccines. For the Chinese soon for us it's a reality.